The role and complications of completion thyroidectomy in the management of well differentiated thyroid cancer
PDF
Cite
Share
Request
Original Article
VOLUME: 22 ISSUE: 2
P: 63 - 66
June 2006

The role and complications of completion thyroidectomy in the management of well differentiated thyroid cancer

Turk J Surg 2006;22(2):63-66
1. İzmir Atatürk Eğitim ve Araştırma Hastanesi 1. Cerrahi Kliniği, İZMİR
No information available.
No information available
PDF
Cite
Share
Request

Abstract

Purpose: The optimal management of completion thyroidectomy after the unexpected diagnosis of misdiagnosed thyroid cancer by means of morbidity and indication. Materials and methods: 30 patients with unexpected diagnosis of thyroid cancer who received completion thyroidectomy were retrospectively reviewed from 2002 to 2005. Rate of residual misdiagnosed cancer and postoperative early and late complications were evaluated. Results: We reviewed the records of 30 patients who underwent completion thyroidectomy because of unexpected diagnosis of well differentiated thyroid cancer. 23 of the patients were women and 7 men with a median age of 49.5 (19 – 75). Residual malignancy was found in 9 patients (30%) after completion thyroidectomy and four patients had lymph node metastases. In seven patients (23.3%) the malignancy was localized in the contralateral lobe. The postoperative morbidity in completion thyroidectomy consisted of transient hypoparathyroidism in five patients (16.6%) (Ca<8mg/dl) and in one patient permanent hypoparathyroidism (longer than 6 months). There was no recurrent laryngeal nerve palsy. Conclusion: For misdiagnosed well differentiated thyroid cancers completion thyroidectomy can be done safely with acceptable morbidity.

Keywords:
Well differentiated thyroid cancer, completion thyroidectomy, complications of thyroidectomy, thyroidectomy

References

1
Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer, 2000; 89: 202–217.
2
Shaha AR, Gleich L, DiMaio T, et al. Accuracy and pitfalls of frozen section during thyroid surgery. J Surg Oncol, 1990; 44: 84–92.
3
Chao T, Jeng L, Lin J, et al. Completion thyroidectomy for differentiated thyroid carcinoma. Otolaryngol Head Neck Surg, 1998; 118: 896–899.
4
Jossart GH, Clark OH. Well differentiated thyroid cancer. Curr Probl Surg, 1994; 31: 935–1011.
5
Eroglu A, Unal M, Kocaoglu H. Total thyroidectomy for differentiated thyroid carcinoma: primary and secondary operations. Eur J Surg Oncol, 1998, 24: 283-287.
6
Kebebew E, Clark OH. Differentiated thyroid cancer: “complete” rational approach. World J Surg, 2000, 24: 942-951.
7
Kupferman ME, Mandel SJ, DiDonato L, et al. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope, 2002, 112: 1209-1212.
8
Clark OH, Levin K, Zeng QH, et al. Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin. Oncol, 1988, 24: 305-313.
9
Hamming JF, Van de Velde CJ, Goslings BM. Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol, 1989, 25: 1317-1323.
10
Hay ID, Grant CS, Taylor WF. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma. Surgery, 1987, 102: 1088-1095.
11
Schroder DM, Chambors A, France CJ. Operative strategy for thyroid cancer. Cancer, 1986, 58: 2320- 2328.
12
Harness JK, McLeod MK, Thompson NW. Death due to differentiated thyroid cancer. W J Surg, 1988, 12: 623-629.
13
DeGroot L J, Kaplan EL, McCormick M. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab, 1990, 71: 414-424.
14
Giles Y, Boztepe H, Terzioglu T, et al. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. Arch Surg, 2004;139:179-182.
15
Greenblatt DY, Woltman T, Harter J, et al. Fine-Needle Aspiration Optimizes Surgical Management in Patients With Thyroid Cancer. Ann Surg Oncol, 2006 Apr 13;[Epub ahead of print]
16
Köybaşıoğlu F, Özakkoyunlu S. Tiroid nodüllerinin tanısında ince iğne aspirasyon sitolojisi ve frozen kesitin değeri. Türk Otolaringoloji Arşivi, 2004;42:210-214.
17
AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.Endocr Pract, 2006;12:63-102.
18
Dewil B, Van Damme B, Vander Poorten V, et al. Completion thyroidectomy after the unexpected diagnosis of thyroid cancer. B-ENT, 2005;1:67-72.
19
Kim ES, Kim TY, Koh JM, et al. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol, 2004;61:145-148.
20
Kupferman ME, Mandel SJ, DiDonato L, et al. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope, 2002;112:1209-12.
21
Kılıç YA. Sayek İ. Tamamlayıcı tiroidektomi. In: Sayek İ. Temel Cerrahi. 3. Baskı. Ankara: Güneş Kitapevi, 2004:1617-1620.
22
El-Zohairy M, Zaher A. Re-operation for the treatment of well differentiated thyroid cancer: necessity, safety and impaction on further management. J Egypt Natl Canc Inst, 2004;16:130-136.
23
Pacini F, Schlumberger M, Harmer C. et al. Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol, 2005;153:651-659.